|
Q2 FY2020
As of Jun 30, 2020
|
Q1 FY2020
As of Mar 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q3 FY2019
As of Sep 30, 2019
|
Q2 FY2019
As of Jun 30, 2019
|
|
|---|---|---|---|---|---|
| ASSETS | |||||
| Current assets: | |||||
| Cash and cash equivalents | |||||
| Short-term investments | |||||
| Accounts receivable, net of allowance for doubtful accounts of $2,774 and $1,245 as of June 30, 2020 and December 31, 2019, respectively | |||||
| Inventories | |||||
| Deferred costs, current | |||||
| Prepaid expenses and other current assets | |||||
| Total current assets | |||||
| Property and equipment, net | |||||
| Operating lease right-of-use assets | |||||
| Restricted cash, noncurrent | |||||
| Goodwill | |||||
| Intangible assets, net | |||||
| Deferred costs, noncurrent | |||||
| Other noncurrent assets | |||||
| TOTAL ASSETS | |||||
| LIABILITIES, REDEEMABLE CONVERTIBLE PREFERRED STOCK, AND STOCKHOLDERS’ EQUITY | |||||
| Current liabilities: | |||||
| Accounts payable | |||||
| Accrued expenses and other current liabilities | |||||
| Deferred revenue, current | |||||
| Advance payments from partner, current | |||||
| Total current liabilities | |||||
| Operating lease liabilities, noncurrent | |||||
| Deferred revenue, noncurrent | |||||
| Advance payment from partner, noncurrent | |||||
| Convertible senior notes, net | |||||
| Other noncurrent liabilities | |||||
| Total Liabilities | |||||
| Redeemable convertible preferred stock, par value of $0.001 per share; zero and 58,615 shares authorized, issued and outstanding as of December 31, 2019 and 2018, respectively; aggregate liquidation preference of zero and $237,650 as of December 31, 2019 and 2018, respectively | |||||
| Stockholders’ equity: | |||||
| Preferred stock, par value of $0.001 per share; 100,000 shares authorized as of June 30, 2020 and December 31, 2019, respectively; zero shares issued and outstanding as of June 30, 2020 and December 31, 2019, respectively | |||||
| Common stock, par value of $0.001 per share; 900,000 shares authorized as of June 30, 2020 and December 31, 2019, respectively; 99,412 and 95,301 shares issued and outstanding as of June 30, 2020 and December 31, 2019, respectively | |||||
| Additional paid-in capital | |||||
| Accumulated deficit | |||||
| TOTAL STOCKHOLDERS’ EQUITY | |||||
| TOTAL LIABILITIES, REDEEMABLE CONVERTIBLE PREFERRED STOCK, AND STOCKHOLDERS’ EQUITY | |||||
| Preferred stock, par value (in dollars per share) | |||||
| Preferred stock, shares authorized (in shares) | |||||
| Preferred stock, shares issued (in shares) | |||||
| Common stock, par value (in dollars per share) | |||||
| Common stock, shares authorized (in shares) |
Loading...
